Ion channel messenger RNA processing defects and arrhythmia

References

• Deo R, Albert CM. Epidemiology and genetics of sudden cardiac death. Circulation. 2012;125(4):620–637.
   Web of Science ®Google Scholar
• Amin AS, Tan HL, Wilde AA. Cardiac ion channels in health and disease. Heart Rhythm. 2010;7(1):117–126.
   PubMed Web of Science ®Google Scholar
• Clancy CE, Kass RS. Defective cardiac ion channels: from mutations to clinical syndromes. J Clin Invest. 2002;110(8):1075–1077.
   Web of Science ®Google Scholar
• Kirsch GE. Ion channel defects in cardiac arrhythmia. J Membr Biol. 1999;170(3):181–190.
   Web of Science ®Google Scholar
• Pfahnl AE, Viswanathan PC, Weiss R, et al. A sodium channel pore mutation causing Brugada syndrome. Heart Rhythm. 2007;4(1):46–53.
   PubMed Web of Science ®Google Scholar
• Remme CA. Cardiac sodium channelopathy associated with SCN5A mutations: electrophysiological, molecular and genetic aspects. J Physiol. 2013;591 Pt 17:4099–4116.
   Google Scholar
• Voudris KV, Apostolakis S, Karyofillis P, et al. Genetic diversity of the KCNE1 gene and susceptibility to postoperative atrial fibrillation. Am Heart J. 2014;167(2):274–280.
   Web of Science ®Google Scholar
• Gao G, Dudley SC Jr. SCN5A splicing variants and the possibility of predicting heart failure-associated arrhythmia. Expert Rev Cardiovasc Ther. 2013;11(2):117–119.
   Google Scholar
• Gao G, Xie A, Huang SC, et al. Role of RBM25/LUC7L3 in abnormal cardiac sodium channel splicing regulation in human heart failure. Circulation. 2011;124(10):1124–1131.
   PubMed Web of Science ®Google Scholar
• Remme CA, Verkerk AO, Hoogaars WM, et al. The cardiac sodium channel displays differential distribution in the conduction system and transmural heterogeneity in the murine ventricular myocardium. Basic Res Cardiol. 2009;104(5):511–522.
   Web of Science ®Google Scholar
• Shang LL, Pfahnl AE, Sanyal S, et al. Human heart failure is associated with abnormal C-terminal splicing variants in the cardiac sodium channel. Circ Res. 2007;101(11):1146–1154.
   PubMed Web of Science ®Google Scholar
• Coronel R, Wilders R, Verkerk AO, Wiegerinck RF, Benoist D, Bernus O. Electrophysiological changes in heart failure and their implications for arrhythmogenesis. Biochim Biophys Acta. 2013;1832(12):2432–2441.
   Web of Science ®Google Scholar
• Duygu B, Poels EM, da Costa Martins PA. Genetics and epigenetics of arrhythmia and heart failure. Front Genet. 2013;4:219.
   PubMedGoogle Scholar
• Farwell D, Gollob MH. Electrical heart disease: genetic and molecular basis of cardiac arrhythmias in normal structural hearts. Can J Cardiol. 2007;23 Suppl A:16A–22A.
   Web of Science ®Google Scholar
• Shah M, Akar FG, Tomaselli GF. Molecular basis of arrhythmias. Circulation. 2005;112(16):2517–2529.
   PubMed Web of Science ®Google Scholar
• Licatalosi DD, Darnell RB. RNA processing and its regulation: global insights into biological networks. Nat Rev Genet. 2010;11(1):75–87.
   PubMed Web of Science ®Google Scholar
• Keene JD. RNA regulons: coordination of post-transcriptional events. Nat Rev Genet. 2007;8(7):533–543.
   PubMed Web of Science ®Google Scholar
• Hsin JP, Manley JL. The RNA polymerase II CTD coordinates transcription and RNA processing. Genes Dev. 2012;26(19):2119–2137.
   PubMed Web of Science ®Google Scholar
• Matera AG, Wang Z. A day in the life of the spliceosome. Nat Rev Mol Cell Biol. 2014;15(2):108–121.
   PubMed Web of Science ®Google Scholar
• Melamed Z, Levy A, Ashwal-Fluss R, et al. Alternative splicing regulates biogenesis of miRNAs located across exon-intron junctions. Mol Cell. 2013;50(6):869–881.
   Web of Science ®Google Scholar
• Jiao X, Xiang S, Oh C, Martin CE, Tong L, Kiledjian M. Identification of a quality-control mechanism for mRNA 5’-end capping. Nature. 2010;467(7315):608–611.
   PubMed Web of Science ®Google Scholar
• Topisirovic I, Svitkin YV, Sonenberg N, Shatkin AJ. Cap and cap-binding proteins in the control of gene expression. Wiley Interdiscip Rev RNA. 2011;2(2):277–298.
   PubMed Web of Science ®Google Scholar
• Hoskins AA, Gelles J, Moore MJ. New insights into the spliceosome by single molecule fluorescence microscopy. Curr Opin Chem Biol. 2011;15(6):864–870.
   Web of Science ®Google Scholar
• Hegele A, Kamburov A, Grossmann A, et al. Dynamic protein-protein interaction wiring of the human spliceosome. Mol Cell. 2012;45(4):567–580.
   PubMed Web of Science ®Google Scholar
• Wahl MC, Will CL, Luhrmann R. The spliceosome: design principles of a dynamic RNP machine. Cell. 2009;136(4):701–718.
   PubMed Web of Science ®Google Scholar
• Kalsotra A, Cooper TA. Functional consequences of developmentally regulated alternative splicing. Nat Rev Genet. 2011;12(10):715–729.
   PubMed Web of Science ®Google Scholar
• Kelemen O, Convertini P, Zhang Z, et al. Function of alternative splicing. Gene. 2013;514(1):1–30.
   PubMed Web of Science ®Google Scholar
• Matlin AJ, Clark F, Smith CW. Understanding alternative splicing: towards a cellular code. Nat Rev Mol Cell Biol. 2005;6(5):386–398.
   PubMed Web of Science ®Google Scholar
• Pan Q, Shai O, Lee LJ, Frey BJ, Blencowe BJ. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet. 2008;40(12):1413–1415.
   PubMed Web of Science ®Google Scholar
• Bielli P, Busa R, Di Stasi SM, et al. The transcription factor FBI-1 inhibits SAM68-mediated BCL-X alternative splicing and apoptosis. EMBO Rep. 2014;15(4):419–427.
   PubMed Web of Science ®Google Scholar
• Kornblihtt AR, de la Mata M, Fededa JP, Munoz MJ, Nogues G. Multiple links between transcription and splicing. RNA. 2004;10(10):1489–1498.
   PubMed Web of Science ®Google Scholar
• Munoz MJ, de la Mata M, Kornblihtt AR. The carboxy terminal domain of RNA polymerase II and alternative splicing. Trends Biochem Sci. 2010;35(9):497–504.
   Web of Science ®Google Scholar
• Moore MJ, Proudfoot NJ. Pre-mRNA processing reaches back to transcription and ahead to translation. Cell. 2009;136(4):688–700.
   PubMed Web of Science ®Google Scholar
• Proudfoot N. New perspectives on connecting messenger RNA 3′ end formation to transcription. Curr Opin Cell Biol. 2004;16(3):272–278.
   PubMed Web of Science ®Google Scholar
• Zhao J, Hyman L, Moore C. Formation of mRNA 3′ ends in eukaryotes: mechanism, regulation, and interrelationships with other steps in mRNA synthesis. Microbiol Mol Biol Rev. 1999;63(2):405–445.
   PubMed Web of Science ®Google Scholar
• Davidson L, West S. Splicing-coupled 3′ end formation requires a terminal splice acceptor site, but not intron excision. Nucleic Acids Res. 2013;41(14):7101–7114.
   PubMed Web of Science ®Google Scholar
• Mapendano CK, Lykke-Andersen S, Kjems J, Bertrand E, Jensen TH. Crosstalk between mRNA 3′ end processing and transcription initiation. Mol Cell. 2010;40(3):410–422.
   PubMed Web of Science ®Google Scholar
• Maquat LE, Tarn WY, Isken O. The pioneer round of translation: features and functions. Cell. 2010;142(3):368–374.
   PubMed Web of Science ®Google Scholar
• Bakheet T, Williams BR, Khabar KS. ARED 3.0: the large and diverse AU-rich transcriptome. Nucleic Acids Res. 2006;34(Database issue): D111–D114.
   Google Scholar
• Beisang D, Rattenbacher B, Vlasova-St Louis IA, Bohjanen PR. Regulation of CUG-binding protein 1 (CUGBP1) binding to target transcripts upon T cell activation. J Biol Chem. 2012;287(2):950–960.
   PubMed Web of Science ®Google Scholar
• Catterall WA. From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels. Neuron. 2000;26(1):13–25.
   PubMed Web of Science ®Google Scholar
• Rook MB, Evers MM, Vos MA, Bierhuizen MF. Biology of cardiac sodium channel Nav1.5 expression. Cardiovasc Res. 2012;93(1):12–23.
   PubMed Web of Science ®Google Scholar
• Zhang T, Yong SL, Tian XL, Wang QK. Cardiac-specific overexpression of SCN5A gene leads to shorter P wave duration and PR interval in transgenic mice. Biochem Biophys Res Commun. 2007;355(2):444–450.
   Web of Science ®Google Scholar
• Gao G, Xie A, Zhang J, et al. Unfolded protein response regulates cardiac sodium current in systolic human heart failure. Circ Arrhythm Electrophysiol. 2013;6(5):1018–1024.
   PubMed Web of Science ®Google Scholar
• Gao G, Brahmanandam V, Raicu M, et al. Enhanced risk profiling of implanted defibrillator shocks with circulating SCN5A mRNA splicing variants: a pilot trial. J Am Coll Cardiol. 2014;63(21):2261–2269.
   PubMed Web of Science ®Google Scholar
• Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol. 1992;20(6):1391–1396.
   PubMed Web of Science ®Google Scholar
• Hong K, Guerchicoff A, Pollevick GD, et al. Cryptic 5′ splice site activation in SCN5A associated with Brugada syndrome. J Mol Cell Cardiol. 2005;38(4):555–560.
   Web of Science ®Google Scholar
• Rossenbacker T, Schollen E, Kuiperi C, et al. Unconventional intronic splice site mutation in SCN5A associates with cardiac sodium channelopathy. J Med Genet. 2005;42(5):e29.
   Web of Science ®Google Scholar
• Shimada T, Ohkubo K, Abe K, Watanabe I, Makita N. A novel 5′ splice site mutation of SCN5A associated with Brugada syndrome resulting in multiple cryptic transcripts. Int J Cardiol. 2012;158(3):441–443.
   Web of Science ®Google Scholar
• Wahbi K, Algalarrondo V, Becane HM, et al. Brugada syndrome and abnormal splicing of SCN5A in myotonic dystrophy type 1. Arch Cardiovasc Dis. 2013;106(12):635–643.
   PubMed Web of Science ®Google Scholar
• Groh WJ, Groh MR, Saha C, et al. Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1. N Engl J Med. 2008;358(25):2688–2697.
   PubMed Web of Science ®Google Scholar
• Buj-Bello A, Furling D, Tronchere H, et al. Muscle-specific alternative splicing of myotubularin-related 1 gene is impaired in DM1 muscle cells. Hum Mol Genet. 2002;11(19):2297–2307.
   Web of Science ®Google Scholar
• Charlet BN, Savkur RS, Singh G, Philips AV, Grice EA, Cooper TA. Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. Mol Cell. 2002;10(1):45–53.
   Web of Science ®Google Scholar
• Walzik S, Schroeter A, Benndorf K, Zimmer T. Alternative splicing of the cardiac sodium channel creates multiple variants of mutant T1620K channels. PLoS One. 2011;6(4):e19188.
   Web of Science ®Google Scholar
• Wang DW, Desai RR, Crotti L, et al. Cardiac sodium channel dysfunction in sudden infant death syndrome. Circulation. 2007;115(3):368–376.
   PubMed Web of Science ®Google Scholar
• Tan BH, Valdivia CR, Song C, Makielski JC. Partial expression defect for the SCN5A missense mutation G1406R depends on splice variant background Q1077 and rescue by mexiletine. Am J Physiol Heart Circ Physiol. 2006;291(4):H1822–H1828.
   PubMed Web of Science ®Google Scholar
• Ludwig A, Zong X, Stieber J, Hullin R, Hofmann F, Biel M. Two pacemaker channels from human heart with profoundly different activation kinetics. EMBO J. 1999;18(9):2323–2329.
   Web of Science ®Google Scholar
• Roden DM, Balser JR, George AL Jr, Anderson ME. Cardiac ion channels. Annu Rev Physiol. 2002;64:431–475.
   PubMed Web of Science ®Google Scholar
• Milanesi R, Baruscotti M, Gnecchi-Ruscone T, DiFrancesco D. Familial sinus bradycardia associated with a mutation in the cardiac pacemaker channel. N Engl J Med. 2006;354(2):151–157.
   PubMed Web of Science ®Google Scholar
• Ueda K, Hirano Y, Higashiuesato Y, et al. Role of HCN4 channel in preventing ventricular arrhythmia. J Hum Genet. 2009;54(2):115–121.
   PubMed Web of Science ®Google Scholar
• Schwartz PJ, Crotti L, Insolia R. Long-QT syndrome: from genetics to management. Circ Arrhythm Electrophysiol. 2012;5(4):868–877.
   PubMed Web of Science ®Google Scholar
• Murray A, Donger C, Fenske C, et al. Splicing mutations in KCNQ1: a mutation hot spot at codon 344 that produces in frame transcripts. Circulation. 1999;100(10):1077–1084.
   Web of Science ®Google Scholar
• Tsuji K, Akao M, Ishii TM, et al. Mechanistic basis for the pathogenesis of long QT syndrome associated with a common splicing mutation in KCNQ1 gene. J Mol Cell Cardiol. 2007;42(3):662–669.
   Web of Science ®Google Scholar
• Tsuji-Wakisaka K, Akao M, Ishii TM, et al. Identification and functional characterization of KCNQ1 mutations around the exon 7-intron 7 junction affecting the splicing process. Biochim Biophys Acta. 2011;1812(11):1452–1459.
   Web of Science ®Google Scholar
• Imai M, Nakajima T, Kaneko Y, et al. A novel KCNQ1 splicing mutation in patients with forme fruste LQT1 aggravated by hypokalemia. J Cardiol. 2014;64(2):121–126.
   Web of Science ®Google Scholar
• Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell. 1995;80(5):795–803.
   PubMed Web of Science ®Google Scholar
• Keating MT, Sanguinetti MC. Molecular and cellular mechanisms of cardiac arrhythmias. Cell. 2001;104(4):569–580.
   PubMed Web of Science ®Google Scholar
• Crotti L, Lewandowska MA, Schwartz PJ, et al. A KCNH2 branch point mutation causing aberrant splicing contributes to an explanation of genotype-negative long QT syndrome. Heart Rhythm. 2009;6(2):212–218.
   Web of Science ®Google Scholar
• Berthet M, Denjoy I, Donger C, et al. C-terminal HERG mutations: the role of hypokalemia and a KCNQ1-associated mutation in cardiac event occurrence. Circulation. 1999;99(11):1464–1470.
   Web of Science ®Google Scholar
• Stump MR, Gong Q, Zhou Z. Multiple splicing defects caused by hERG splice site mutation 2592+1G. A associated with long QT syndrome. Am J Physiol Heart Circ Physiol. 2011;300(1):H312–H318.
   Web of Science ®Google Scholar
• Gong Q, Zhang L, Moss AJ, et al. A splice site mutation in hERG leads to cryptic splicing in human long QT syndrome. J Mol Cell Cardiol. 2008;44(3):502–509.
   Web of Science ®Google Scholar
• Fukuyama M, Ohno S, Wang Q, Shirayama T, Itoh H, Horie M. Nonsense-mediated mRNA decay due to a CACNA1C splicing mutation in a patient with Brugada syndrome. Heart Rhythm. 2014;11(4):629–634.
   PubMed Web of Science ®Google Scholar
• Farris S, Lewandowski G, Cox CD, Steward O. Selective localization of arc mRNA in dendrites involves activity- and translation-dependent mRNA degradation. J Neurosci. 2014;34(13):4481–4493.
   PubMed Web of Science ®Google Scholar
• Schoenberg DR, Maquat LE. Regulation of cytoplasmic mRNA decay. Nat Rev Genet. 2012;13(4):246–259.
   PubMed Web of Science ®Google Scholar
• Chen K, Rajewsky N. The evolution of gene regulation by transcription factors and microRNAs. Nat Rev Genet. 2007;8(2):93–103.
   PubMed Web of Science ®Google Scholar
• Pillai RS, Bhattacharyya SN, Artus CG, et al. Inhibition of translational initiation by Let-7 microRNA in human cells. Science. 2005;309(5740):1573–1576.
   PubMed Web of Science ®Google Scholar
• Bagga S, Bracht J, Hunter S, et al. Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation. Cell. 2005;122(4):553–563.
   PubMed Web of Science ®Google Scholar
• Jing Q, Huang S, Guth S, et al. Involvement of microRNA in AU-rich element-mediated mRNA instability. Cell. 2005;120(5):623–634.
   PubMed Web of Science ®Google Scholar
• Girmatsion Z, Biliczki P, Bonauer A, et al. Changes in microRNA-1 expression and IK1 up-regulation in human atrial fibrillation. Heart Rhythm. 2009;6(12):1802–1809.
   Web of Science ®Google Scholar
• Duisters RF, Tijsen AJ, Schroen B, et al. miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling. Circ Res. 2009;104(2):170–178.
   PubMed Web of Science ®Google Scholar
• Tanaka K, Zlochiver S, Vikstrom KL, et al. Spatial distribution of fibrosis governs fibrillation wave dynamics in the posterior left atrium during heart failure. Circ Res. 2007;101(8):839–847.
   PubMed Web of Science ®Google Scholar
• Wang GK, Zhu JQ, Zhang JT, et al. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J. 2010;31(6):659–666.
   PubMed Web of Science ®Google Scholar
• Fichtlscherer S, Zeiher AM, Dimmeler S. Circulating microRNAs: biomarkers or mediators of cardiovascular diseases? Arterioscler Thromb Vasc Biol. 2011;31(11):2383–2390.
   PubMed Web of Science ®Google Scholar
• Turchinovich A, Weiz L, Burwinkel B. Extracellular miRNAs: the mystery of their origin and function. Trends Biochem Sci. 2012;37(11):460–465.
   PubMed Web of Science ®Google Scholar
• Creemers EE, Tijsen AJ, Pinto YM. Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? Circ Res. 2012;110(3):483–495.
   PubMed Web of Science ®Google Scholar
• Morley-Smith AC, Mills A, Jacobs S, et al. Circulating microRNAs for predicting and monitoring response to mechanical circulatory support from a left ventricular assist device. Eur J Heart Fail. 2014;16(8):871–879.
   PubMed Web of Science ®Google Scholar
• Dawson K, Wakili R, Ordog B, et al. MicroRNA29: a mechanistic contributor and potential biomarker in atrial fibrillation. Circulation 2013;127(14):1466–1475.
   PubMed Web of Science ®Google Scholar